IL6 and diabetes mellitus: Characterized by chronic low-grade inflammation, diabetes alters the expression of key inflammatory mediators such as monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), and C-C motif chemokine receptor 2 (CCR2), which collectively modulate peripheral and central immune responses (31).